UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 97

Sortiert nach

Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes

Diabetes care, 2016-08, Vol.39 (8), p.1408-1415

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes

PloS one, 2014-08, Vol.9 (8), p.e105638

2014

Link zum Volltext

Verfügbarkeit prüfen

Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development

2nd ed. 2019, 2019

Link zum Volltext

Verfügbarkeit prüfen

Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH

Endocrinology, diabetes & metabolism, 2022-05, Vol.5 (3), p.e00335-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients

Endocrinology, diabetes & metabolism, 2021-04, Vol.4 (2), p.e00217-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes

PloS one, 2014, Vol.9 (9), p.e110069

2014

Link zum Volltext

Verfügbarkeit prüfen

Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients

PloS one, 2018, Vol.13 (12), p.e0208998-e0208998

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study

BMJ open diabetes research & care, 2021-06, Vol.9 (1), p.e002208

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline

BMJ open diabetes research & care, 2022-01, Vol.10 (1), p.e002207

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and Pharmacodynamic Responses of Insulin Degludec in African American, White, and Hispanic/Latino Patients With Type 2 Diabetes Mellitus

Clinical therapeutics, 2014-04, Vol.36 (4), p.507-515

2014

Link zum Volltext

Verfügbarkeit prüfen

Biosimilar Insulins: Basic Considerations

Journal of diabetes science and technology, 2014-01, Vol.8 (1), p.6-13

2014

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin

Clinical pharmacology and therapeutics, 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

774-P: Weight-Independent Effects of CT-868, a Signaling Biased Dual GLP-1/GIP Receptor Modulator, on Glucose Homeostasis in Overweight and Obese Adults with Type 2 Diabetes

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

SAT-451 - Serological biomarkers of extracellular matrix related disease activity are elevated in patients at risk of NASH with significant liver stiffness

Journal of hepatology, 2023-06, Vol.78, p.S688-S688

2023

Link zum Volltext

Verfügbarkeit prüfen

Serological biomarkers of extracellular matrix related disease activity are elevated in patients at risk of NASH with significant liver stiffness

Journal of hepatology, 2023-06, Vol.78, p.S688

2023

Link zum Volltext

Verfügbarkeit prüfen

901-P: Evaluation of the Analytical Performance of YSI 2900D Compared with YSI 2300 STAT Plus for Glucose Concentration Measurements

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long‐acting glucagon analogue HM15136 in overweight and obese patients with co‐morbidities

Diabetes, obesity & metabolism, 2023-09, Vol.25 (9), p.2723-2733

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin

Journal of Diabetes Science and Technology, 2017-01, Vol.11 (1), p.148-156

2017

Link zum Volltext

Verfügbarkeit prüfen

Antisense Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes

Journal of clinical lipidology, 2016-05, Vol.10 (3), p.707-708

2016

Link zum Volltext

Verfügbarkeit prüfen

Biosimilar insulins: how similar is similar?

Journal of diabetes science and technology, 2011-05, Vol.5 (3), p.741-754

2011

Link zum Volltext

Verfügbarkeit prüfen

805-P: Double-Blind Crossover Study of Ultra-Rapid AT247 Compared with NovoLog and Fiasp during Continuous Subcutaneous Infusion (CSII) Assessed by a Hyperinsulinemic Euglycemic Clamp

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption

The journal of clinical endocrinology and metabolism, 2020-04, Vol.105 (4), p.e1235-e1249

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin (rDNA origin) in 0.9% sodium chloride ready‐to‐use infusion 1 U/mL and 100 U/mL concentrate diluted to 1 U/mL in healthy males

Diabetes, obesity & metabolism, 2021-12, Vol.23 (12), p.2679-2686

2021

Link zum Volltext

Verfügbarkeit prüfen

Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study

Diabetes care, 2018-11, Vol.41 (11), p.2346-2352

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Englisch
(97)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(44)
Science & Technology
(42)
Life Sciences & Biomedicine
(39)
Diabetes
(36)
Male
(31)
Endocrinology & Metabolism
(30)
Insulin
(30)
Female
(27)
Adult
(26)
Middle Aged
(24)
Diabetes Mellitus, Type 2 - Drug Therapy
(20)
Pharmacodynamics
(20)
Pharmacokinetics
(20)
Diabetes Mellitus
(18)
Double-Blind Method
(18)
Glucose
(18)
Cross-Over Studies
(15)
Hypoglycemic Agents - Administration & Dosage
(14)
Hypoglycemic Agents - Pharmacokinetics
(13)
Hypoglycemic Agents - Therapeutic Use
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes

Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes

CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes

Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development

Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH

Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients

Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes

Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients

Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study

Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline

Pharmacokinetic and Pharmacodynamic Responses of Insulin Degludec in African American, White, and Hispanic/Latino Patients With Type 2 Diabetes Mellitus

Biosimilar Insulins: Basic Considerations

A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin

774-P: Weight-Independent Effects of CT-868, a Signaling Biased Dual GLP-1/GIP Receptor Modulator, on Glucose Homeostasis in Overweight and Obese Adults with Type 2 Diabetes

SAT-451 - Serological biomarkers of extracellular matrix related disease activity are elevated in patients at risk of NASH with significant liver stiffness

Serological biomarkers of extracellular matrix related disease activity are elevated in patients at risk of NASH with significant liver stiffness

901-P: Evaluation of the Analytical Performance of YSI 2900D Compared with YSI 2300 STAT Plus for Glucose Concentration Measurements

Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long‐acting glucagon analogue HM15136 in overweight and obese patients with co‐morbidities

Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin

Antisense Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes

Biosimilar insulins: how similar is similar?

805-P: Double-Blind Crossover Study of Ultra-Rapid AT247 Compared with NovoLog and Fiasp during Continuous Subcutaneous Infusion (CSII) Assessed by a Hyperinsulinemic Euglycemic Clamp

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption

Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin (rDNA origin) in 0.9% sodium chloride ready‐to‐use infusion 1 U/mL and 100 U/mL concentrate diluted to 1 U/mL in healthy males

Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study

Suchergebnisse filtern